Patient Guided Psychiatric Admissions

March 31, 2017 updated by: St. Olavs Hospital

Patient Guided Psychiatric Admissions (Self-referral to Inpatient Beds)

To meet the requirement for increased patient involvement, several Community Mental Health Centres (CMHC) have initiated a service called "patient-guided admissions". The investigators will compare a group with "patient guided admission/self-referral to inpatient beds" with a group having treatment as usual.

It is expected that patients in the intervention group will experience more increased feeling of coping (patient activation) after 4 months and 12 months as a result of participating in "patient-guided admissions" than patients getting treatment as usual. In addition the total number of inpatient days either in the CMHC, psychiatric hospital or community rehabilitation centre is expected to be clearly lower in the intervention group than in the 'treatment-as-usual' group during one year after intake. Also the number of involuntary admissions either as inpatient or outpatient will be significant lower in the intervention group than the 'treatment-as-usual' group.The number of admissions in CMHC and psychiatric hospital, as well as the number of outpatient consultations in primary care, CMHC and psychiatric hospitals, will be lower in the intervention group than in the 'treatment-as-usual' group. Patients in the intervention group will experience improved mental health, increased feeling of coping (patient activation) and increased experience of recovery after 4 months and 12 months as a result of participating in "patient-guided admissions".

Study Overview

Detailed Description

Participants will be patients with psychosis or bipolar disorders. Patients in the intervention group will have a contract on "self-referral to inpatient beds" for one year. They can call the CMHC directly and ask for a bed for until 5 nights.

The patients in the 'treatment-as-usual' group will follow common procedures by either contacting their general practitioner, emergency department or duty doctor, and they will be offered a "self-referral to inpatient bed" contract after a year if they satisfy the inclusion criteria.

Regardless of the participation in the intervention group, the patients can also be ordinary admitted during the project period by a doctor via regular procedures in both hospital and CMHC if there is a need for this. All admissions will appear in the register data.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trondheim, Norway, 7440
        • St.Olavs hospital, Psykisk helsevern, Nidaros DPS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • schizophrenia or bipolar disorder
  • long term care
  • established relationship with the ward

Exclusion Criteria:

  • extensive substance use problems
  • self-destructive behavior
  • not able to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: admissions contract
contract regarding "patient-guided admissions"
contract regarding "patient-guided admissions" starting immediately
Active Comparator: wait list control
1 year on waiting list
Patient-guided admissions contract regarding "patient-guided admissions" starting a year after.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient activation/coping
Time Frame: 4 months
Patient Activation Measure (PAM 13)
4 months
Patient activation/coping
Time Frame: 12 months
Patient Activation Measure (PAM 13)
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of admissions
Time Frame: 12 months
Number of admissions in CMHC, psychiatric hospital of community rehabilitation centre
12 months
Total number of inpatient days
Time Frame: 12 months
Total number of inpatient days in CMHC, psychiatric hospital or community rehabilitation centre
12 months
Number of outpatient consultations
Time Frame: 12 months
Number of outpatient consultations in primary care, in CMHC and psychiatric hospital
12 months
Number of involuntary admissions
Time Frame: 12 months
Number of involuntary admissions either as inpatient or outpatient
12 months
Symptoms/functioning and recovery
Time Frame: 4 months
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
4 months
Symptoms/functioning and recovery
Time Frame: 12 months
Behavior and symptom identification scale (BASIS 32) and Recovery Assessment Scale (RAS 24)
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lasse Eriksen, PhD, St. Olavs Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

May 19, 2010

First Submitted That Met QC Criteria

May 28, 2010

First Posted (Estimate)

May 31, 2010

Study Record Updates

Last Update Posted (Actual)

April 4, 2017

Last Update Submitted That Met QC Criteria

March 31, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2009/1704 (Other Grant/Funding Number: St Olavs Hospital)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on admissions contract

Subscribe